Jeffrey Fudin, PharmD, DAIPM, FCCP, FASHP, FFSMB

Oliceridine (Olinvyk) expands options for managing moderate to severe acute pain, but cost, drug-drug interactions, and other factors come into play.

Peripherally acting M-opioid receptor antagonists can improve quality of life but differ variably by impact from concomitant medications.

Panic and a host of interactions are entwined with disease-modifying antirheumatic drugs.

Recent federal legalization and increases sales of CBD underscore the importance of considering its pharmacologic impact.

Common medications containing polyvalent cations should be separated to prevent decreased absorption of the HIV therapy.

Pharmacists play a crucial role in assessing clinical significance and severity and, when appropriate, recommending alternative therapy.

SSRIs have been shown to inhibit reuptake of serotonin in platelets, ultimately impairing platelet aggregation.

Using a drug that increases GABA synthesis and possibly escalates intraneuronal dopamine in a population that is more likely to have behavior health concerns may prove to be an unsafe option.